I Don't Like Taking Medication
To those of you (and you know who you are) who have been pimping hyrodxychloroquine as a wonder cure or preventative for COVID-19, and using as a political tool to bash scientists and elected officials for listening to the scientists and being cautious in authorizing its wide use, please just stop.
Yesterday, the 5th study in a row showed that hyrodxychloroquine had no beneficial effect on groups of COVID-19 patients to whom it was administered. One of the studies showed a significantly greater death rate in seriously ill patients to whom it was administered. Another had to be terminated due to heart irregularities in the study group.
It is possible that in a few instances it helped individual patients. But it is also quite possible that it had no effect positive or negative on these individuals and they recovered due to other associated care, because the antibiotic that it has been paired with helped them fight off bacterial infection that took hold because of their compromised immune system or that they were simply lucky.
There are multiple treatments being studied, some of which are showing promise. But the hype about hyrodxychloroquine and the expense of its associated stockpiling (and the scarcity for people with Lupus) has done more harm than good.
Time to turn back to Science.
Yesterday, the 5th study in a row showed that hyrodxychloroquine had no beneficial effect on groups of COVID-19 patients to whom it was administered. One of the studies showed a significantly greater death rate in seriously ill patients to whom it was administered. Another had to be terminated due to heart irregularities in the study group.
It is possible that in a few instances it helped individual patients. But it is also quite possible that it had no effect positive or negative on these individuals and they recovered due to other associated care, because the antibiotic that it has been paired with helped them fight off bacterial infection that took hold because of their compromised immune system or that they were simply lucky.
There are multiple treatments being studied, some of which are showing promise. But the hype about hyrodxychloroquine and the expense of its associated stockpiling (and the scarcity for people with Lupus) has done more harm than good.
Time to turn back to Science.
61-69, M
